D-0451-2026 Class II Ongoing

Recalled by Cipla USA, Inc. — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
April 22, 2026
Initiation Date
March 16, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
63,192 bottles

Product Description

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

Reason for Recall

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Distribution Pattern

Nationwide in the USA

Code Information

Lot, expiry: 4PB0224, exp March-2026; 4PB0505, 4PB0506, 4PB0507, exp September-2026; 5PB0564, exp April-2027